Author

Jonathan J. Waataja

Observed names: J. Wataaja, Jon J. Waataja, Jonathan J Waataja, Jonathan Waataja

Institution: ReShape Lifesciences (United States)

Observed institutions: University of Minnesota, ReShape Lifesciences (United States)

ORCID: 0009-0000-3917-0865

Observed ORCID: 0009-0000-3917-0865

OpenAlex ID: A5000821309

Δ9-Tetrahydrocannabinol protects hippocampal neurons from excitotoxicity

2006 · Glenna L. Gilbert, Hee Jung Kim, et al. · Brain Research · 81

Effects of high-frequency alternating current on axonal conduction through the vagus nerve

2011 · Jonathan J Waataja, Katherine S Tweden, et al. · Journal of Neural Engineering · 79

PDF

Subcellular Targeting of RGS9-2 Is Controlled by Multiple Molecular Determinants on Its Membrane Anchor, R7BP

2006 · Joseph H. Song, Jonathan J. Waataja, et al. · Journal of Biological Chemistry · 66

PDF

Excitotoxic loss of post‐synaptic sites is distinct temporally and mechanistically from neuronal death

2007 · Jonathan J. Waataja, Hee Jung Kim, et al. · Journal of Neurochemistry · 53

Cannabinoids Inhibit Network-Driven Synapse Loss between Hippocampal Neurons in Culture

2008 · Hee Jung Kim, Jonathan J. Waataja, et al. · Journal of Pharmacology and Experimental Therapeutics · 39

Involvement of the VGF-derived peptide TLQP-62 in nerve injury–induced hypersensitivity and spinal neuroplasticity

2018 · Alexander G. J. Skorput, Xijing Zhang, et al. · Pain · 16

Agmatine preferentially antagonizes GluN2B-containing N -methyl- d -aspartate receptors in spinal cord

2018 · Jonathan J. Waataja, Cristina D. Peterson, et al. · Journal of Neurophysiology · 15

PDF

Long-term reversal of chronic pain behavior in rodents through elevation of spinal agmatine

2023 · Cristina D. Peterson, Jonathan J. Waataja, et al. · Molecular Therapy · 14

Combining Celiac and Hepatic Vagus Nerve Neuromodulation Reverses Glucose Intolerance and Improves Glycemic Control in Pre- and Overt-Type 2 Diabetes Mellitus

2023 · Jonathan J. Waataja, Anders J. Asp, et al. · Biomedicines · 11

PDF

Use of a bio-electronic device comprising of targeted dual neuromodulation of the hepatic and celiac vagal branches demonstrated enhanced glycemic control in a type 2 diabetic rat model as well as in an Alloxan treated swine model

2022 · Jonathan J. Waataja, Raj K. Nihalani, et al. · Frontiers in Neuroscience · 10

PDF

Vagal Nerve Block for Improvements in Glycemic Control in Obese Patients with Type 2 Diabetes Mellitus: Three-Year Results of the VBLOC DM2 Study

2016 · Katherine Tweden, Miguel F Herrera, et al. · Journal of Diabetes and Obesity · 10

PDF

The Duration and Intensity of High Frequency Alternating Current Influences the Degree and Recovery of Nerve Conduction Block

2024 · Jonathan J. Waataja, Christopher N. Honda, et al. · IEEE Transactions on Biomedical Engineering · 1

Perspective Chapter: Exploring the Potential of Vagus Nerve Neuromodulation as a Personalized and Enhanced Therapeutic Experience for Type 2 Diabetics

2023 · Jonathan Waataja, Sayeed Ikramuddin, et al. · IntechOpen eBooks · 1

PDF

Neuromodulation – the future of diabetes treatments

2023 · Jonathan Waataja · Research outreach

PDF

(219) Selective Antagonism of Spinal GluN2B EPSCs by Agmatine

2019 · C. Peterson, J. Wataaja, et al. · Journal of Pain

Agmatine reduction of neuropathic pain requires spinal NMDA receptors containing GluN2B subunits

2018 · C. Peterson, J. Wataaja, et al. · Journal of Pain

Works count: 17

Citation count: 396

H-index: 10

I10-index: 11